Guggenheim Remains a Buy on Exelixis (EXEL)
Guggenheim analyst Michael Schmidt maintained a Buy rating on Exelixis (EXEL – Research Report) on March 26 and set a price target of $42.00.
Piper Sandler Keeps Their Buy Rating on Phreesia (PHR)
In a report released on March 27, Jessica Tassan from Piper Sandler reiterated a Buy rating on Phreesia (PHR – Research Report), with a price ...